P Marona, J Górka, O Kwapisz,
J Jura, J Rys… - Cell Death & …, 2022 - nature.com
Tyrosine kinase inhibitors (TKIs) are the most commonly used targeted therapeutics in clear-
cell renal cell carcinoma (ccRCC); however, drug resistance limits their utility and can lead …